Cited by 199Genetic Syndromes and ImprintingGenomic variations and chromosomal abnormalitiesGenetics and Neurodevelopmental Disorders

Chromosome 15q11–13 duplication syndrome brain reveals epigenetic alterations in gene expression not predicted from copy number

Open access
Hogart, A, Leung, K N, Wang, N J, Wu, D J, Driscoll, J, Vallero, R O, Schanen, N C, LaSalle, J M·2009·Journal of Medical Genetics

Abstract

Background: Chromosome 15q11–13 contains a cluster of imprinted genes essential for normal mammalian neurodevelopment. Deficiencies in paternal or maternal 15q11–13 alleles result in Prader–Willi or Angelman syndromes, respectively, and maternal duplications lead to a distinct condition that often includes autism. Overexpression of maternally expressed imprinted genes is predicted to cause 15q11–13-associated autism, but a link between gene dosage and expression has not been experimentally determined in brain. Methods: Postmortem brain tissue was obtained from a male with 15q11–13 hexasomy and a female with 15q11–13 tetrasomy. Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) was used to measure 10 15q11–13 transcripts in maternal 15q11–13 duplication, Prader–Willi syndrome, and control brain samples. Southern blot, bisulfite sequencing and fluorescence in situ hybridisation were used to investigate epigenetic mechanisms of gene regulation. Results: Gene expression and DNA methylation correlated with parental gene dosage in the male 15q11–13 duplication sample with severe cognitive impairment and seizures. Strikingly, the female with autism and milder Prader–Willi-like characteristics demonstrated unexpected deficiencies in the paternally expressed transcripts SNRPN, NDN, HBII85, and HBII52 and unchanged levels of maternally expressed UBE3A compared to controls. Paternal expression abnormalities in the female duplication sample were consistent with elevated DNA methylation of the 15q11–13 imprinting control region (ICR). Expression of non-imprinted 15q11–13 GABA receptor subunit genes was significantly reduced specifically in the female 15q11–13 duplication brain without detectable GABRB3 methylation differences. Conclusion: Our findings suggest that genetic copy number changes combined with additional genetic or environmental influences on epigenetic mechanisms impact outcome and clinical heterogeneity of 15q11–13 duplication syndromes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jmg.2008.061580

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Maternal duplications of the 15q11-13 locus lead to increased expression of UBE3A and epigenetic silencing of the paternal antisense transcript, UBE3A-ATS.

    “Maternal duplications of the 15q11–13 locus lead to increased expression of UBE3A and epigenetic silencing of the paternal antisense transcript, UBE3A-ATS121–124.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [19]Kubota T Das S Christian SL Methylation-specific PCR simplifies imprinting analysis [letter] Nat Genet 1997 16 1 16 7 9140389

Cited by

Sorted by citations

Authors
Hogart, A., Leung, K. N., Wang, N. J., Wu, D. J., Driscoll, J., Vallero, R. O., Schanen, N. C., & LaSalle, J. M.
Affiliations
  • University of California, Davis (US)
  • University of Delaware (US)
  • Alfred I. duPont Hospital for Children (US)
Corresponding author
LaSalle, J M
Venue
Journal of Medical Genetics
Publisher
BMJ
Published
2008-10-03
Volume
46
Issue
2
Pages
86-93
ISSN
  • 0022-2593 (ISSN-L)
  • 1468-6244
OpenAlex
W2124390364
Cited by
199
References
39
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 4 · 2022: 6 · 2021: 7 · 2020: 2 · 2019: 7 · 2018: 37 · 2017: 4 · 2016: 5 · 2015: 9 · 2014: 12 · 2013: 14 · 2012: 18
FWCI
13.14
Type
journal article
Language
en
Open access
Locations
  • Journal of Medical Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (1c06rr012088-01)
  • National Institute of Mental Health (R24MH068855, F31MH078377)
  • National Center for Research Resources (P20RR020173, C06-RR012088, C06 RR-12088-01)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (U19 HD 35470, U19HD035470, R01HD048799)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
genomic imprinting, DNA methylation, gene dosage, Prader-Willi syndrome, Angelman syndrome, autism spectrum disorder, UBE3A, SNRPN, NDN, GABRB3, GABA receptor subunits, imprinting control regions, brain gene expression, copy number variation, clinical heterogeneity
MeSH terms
Adolescent, Adult, Aneuploidy, Brain, Chromosomes, Human, Pair 15, Female, Humans, Male, Prader-Willi Syndrome, Syndrome, Gene Expression, Angelman Syndrome, Gene Dosage, DNA Methylation, Gene Duplication, Epigenesis, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review